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Facial nerve damage has a detrimental effect on a patient’s life, therefore safety
mechanisms to ensure its preservation are essential during lateral skull base surgery.
During robotic cochlear implantation a trajectory passing the facial nerve at <0.5mm is
needed. Recently a stimulation probe and nerve monitoring approach were developed
and introduced clinically, however for patient safety no trajectory was drilled closer than
0.4mm. Here we assess the performance of the nerve monitoring system at closer
distances. In a sheep model eight trajectories were drilled to test the setup followed
by 12 trajectories during which the ENT surgeon relied solely on the nerve monitoring
system and aborted the robotic drilling process if intraoperative nerve monitoring
alerted of a distance <0.1mm. Microcomputed tomography images and histopathology
showed prospective use of the technology prevented facial nerve damage. Facial nerve
monitoring integrated in a robotic system supports the surgeon’s ability to proactively
avoid damage to the facial nerve during robotic drilling in the mastoid.
Keywords: robotic surgery, robotic cochlear implantation, neurophysiology monitoring, monopolar and bipolar,
nerve stimulation electrode
INTRODUCTION
Cochlear implants allow to treat severe sensorineural deafness and so far more than 324,200 (by the
end of 2012) have been implanted worldwide (1). If a patient’s residual hearing can be preserved
during surgery, speech recognition is improved (2). Key-hole approaches to the middle and inner
ear for cochlear implantation can automate the drilling process and electrode insertion can be more
consistent with hypothesized better auditory outcomes (3, 4). The conventional mastoidectomy
and posterior tympanotomy is replaced by a linear tunnel reaching from the mastoid surface to the
insertion site on the cochlea, passing between the facial nerve and the chorda tympani at distances
of <1mm (5, 6). Optimal electrode insertion angles even advocate a margin of <0.5mm (7). Facial
nerve damage has detrimental effects on a patient’s life (8). Therefore, in the conventional approach,
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the facial nerve is surgically exposed (skeletonized) and risk
of facial nerve palsy is minimal (<0.8 %) (9), in most cases
only a transitory problem. However, during a keyhole approach
sufficient clearance cannot be confirmed visually, hence accurate
stereotactic image guidance technology is required, backed up by
redundancy to provide for fail safe operation.
Clinically, key-hole cochlear implantation using patient-
specific stereotactic frames (10) and our previously reported
task specific robot system (11–13) have been demonstrated.
We consider surgical robotic technology to be superior over
stereotactic frames, as it can control forces, irrigation and
feed forward rates accurately during drilling processes and
provide coherent integration of necessary safety mechanisms
(14). Among other safety elements, we had integrated facial
nerve monitoring (FNM) to trace the functional integrity of
nerves during the first attempts of robotic keyhole surgery (3, 4)
(Figure 1).
Intraoperative nerve monitoring was first proposed for
use in lateral skull base surgery (15) and was subsequently
introduced to many other surgical disciplines such as Ear-nose-
throat (ENT) (8, 16), spinal (17, 18), and cranial neurosurgery
(19, 20). While facial nerve monitoring has become a well-
accepted clinical utility during certain otologic surgeries (21,
22), our understanding of its performance during key-tunneling
approaches is still in its infancy. We previously demonstrated,
that conventional monopolar facial nerve monitoring is of only
limited use during robotic middle ear access, because it does
not give conclusive feedback of nerve proximity at close range
(<1mm) (23).
Hence, we proposed a nerve monitoring approach with
variable monopolar and bipolar stimulation intensity and where
muscle response are analyzed to determine whether a surgical
drill is too close to the facial nerve (24) (Figure 1). As the
drill passes the facial nerve, stimulus thresholds (minimum
stimulation intensity evoking a muscle action potential response)
are sampled at pre-defined locations. The bipolar configurations
have a localized electrical field, allowing to distinguish nerve
proximity at closer distances than the monopolar configuration
(19). In an initial pre-clinical in vivo experience, the system
was able to determine potential collisions (distance <0.1mm,
stimulation threshold <0.35mA) with the facial nerve (24).
Different stimulation channels provide different penetration
depths of the electrical current, thus higher sensitivity is
associated to a monopolar configuration and higher specificity
to a bipolar. From four stimulation channels studied (bipolar
1, 2, 3, and monopolar), it was demonstrated that bipolar
stimulation (distance cathode-anode of 2mm) is the most
reliable to determine a potential collision with the facial nerve
(<0.1mm). The system was then introduced clinically (25) in six
patients, and its predicted facial nerve clearance correlated with
the distances measured in the intraoperative CT scans (12). For
patient safety, trajectories were drilled with a safety margin to the
facial nerve of 0.4 mm.
Here, we aim to validate the performance of the system
in distance ranges between potential collision and sufficient
clearance to the facial nerve (0.0 < distance < 0.4mm). We
hypothesize that the surgeon is able to abort the robot assisted
procedure based on the facial nerve monitoring feedback,
without support on systems navigation, before structurally
damaging the facial nerve. We carried out an in vivo study
(sheep model), where trajectories were planned and drilled in the
mastoid at pre-defined low distances from the facial nerve. The
ENT surgeon stopped the drill process if the system suggested
a collision with the facial nerve. Post-mortem micro-computed
tomography images and histopathology were used to evaluate
the nerve monitoring system’s ability to support the surgeon in
avoiding facial nerve structural damage.
MATERIALS AND METHODS
In-vivo Experiment
Study Design
The study was approved by the Bernese cantonal animal
commission (license number BE56/12). The study was designed
as prospective and observer-blinded. In total, a number of
24 drilling attempts (eight trajectories in three animals) with
varying distances (0 to 1.5mm) to the facial nerve were carried
out. Following a redesign of a FNM stimulation probe as
part of a commercial development and in order to confirm
expected system performance (24, 25), the first animal served for
training (training trajectories) and the last two for prospective
assessment of the nerve monitoring approach. In the training
trajectories, the surgeon is asked to continue drilling even
if the system suggests of a collision with the facial nerve.
In the prospective trajectories the surgeon will stop robotic
drilling in case the system suggests collision with the facial
nerve. A sheep model was chosen, because it provides similar
mastoid and facial nerve anatomy to human (26), whilst
the non-existence of air cells (27) is considered to be of
no relevance.
Per drill attempt, the trajectory was planned using pre-
operative computed tomography image data and drilled by
a surgical robotic system for cochlear implantation. Nerve
monitoring was applied at pre-defined positions near the
facial nerve. The system was operated by an ENT surgeon
who was not aware of the specifics of the drill trajectory
relative to the facial nerve (observer role). After each nerve
monitoring measurement, the ENT surgeon was presented with
the findings of the measurement and asked to terminate or
continue the drilling process based on stimulation threshold of
0.35mA derived from a previous study (25). After completion
of all trajectories, the subject was sacrificed by 0.5 ml/kg
pentobarbital 40%. The mastoid bone region was extracted for
post-operative micrometer resolution computed tomography.
Potential structural damage of the facial nerve in the proximity of
the drilled trajectories was studied via histopathological analysis
of each mastoid.
Anesthesia Protocol
Animals were pre-medicated with 0.1 mg/kg diazepam and 0.01
mg/kg fentanyl administered intravenously. General anesthesia
was induced with an intravenous injection of propofol 1% to
effect. Endotracheal intubation was performed, whereby the
anesthetic state wasmaintained by isoflurane in 100% oxygen and
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FIGURE 1 | Robotic cochlear implantation supported by facial nerve monitoring. Robotic drilling is performed from the surface of the mastoid to a first safety point
3mm before the facial nerve (yellow) and the chorda tympani nerve (pink). The robot drill is retracted and the stimulating probe with monopolar and bipolar
configurations (Bipolar 1,2,3) is inserted to the end of the trajectory, following application of a stimulation intensity ramp (0.2–2mA, 4Hz, 250 µs). The minimum
intensity that elicits a muscle evoked potential above threshold is registered for each configuration. Different stimulus thresholds are expected to provide different
prediction of distance to the facial nerve. A stimulation intensity above 0.35mA (bipolar configuration) suggest sufficient facial nerve distance to ensure structural
preservation of the facial nerve (e.g., 1mA stimulus threshold bipolar B1).
fentanyl 0.01 mg/kg/h. Ringers lactate solution was administered
at a rate of 5 ml/kg/h. Neuromuscular blockade was avoided to
ensure normal facial nerve activity.
Site Preparation, Imaging, and Planning
The temporalis muscle was excised and four titanium reference
screws (2.2mm diameter× 5mm length, Medartis, Switzerland)
were implanted near the external auditory canal for subject-
to-image registration (28). A CT image (0.4mm space between
slices, 0.8mm slice thickness) of the animal’s head was acquired
(Brilliance, Philips AG). A modified version of an otologic
surgical planning software (OTOPLANTM) (CAScination AG,
Switzerland) (29) was used to segment the facial nerve and
to plan the drilling trajectories (1.8mm Ø) relative to the
segmented facial nerve. In subject 1 (training trajectories) an
intraoperative O-arm system (Medtronic) was used for pre-
operative imaging due to a technical problem with the CT
system (0.415mm pixel spacing, 0.8mm slice thickness). In
each animal eight drilling trajectories were planned relative to
the segmented facial nerve (Figure 2a). Five trajectories were
defined with closest lateral distances (LD) of 0.5mm (T0),
0.3mm (T2, T4), and 0.0mm (T1, T3). Three trajectories
were planned to frontally intersect with the facial nerve (T5,
T6, T7). On each trajectory five measurement points (PN,
N = 5) were defined (Figure 2b). For the lateral trajectories
the first point was defined at an axial distance of 1.2mm
before the facial nerve center and the last point 0.9mm after
(axial increments of 0.54mm) (25). In frontal trajectories,
the first measurement point was 1.2mm before the facial
nerve canal and the last point 0.3mm inside (axial increments
0.375mm). Trajectories are herein after referred to by two
attributed numbers (x.y): the subject number (1–3) and
the trajectory number (0–7), e.g., subject 1 trajectory 6 is
labeled as 1.6.
Electromyography Setup
Two pairs of subdermal electromyography (EMG) needles (SDN
Trigon, Inomed, Germany) were inserted into the facial muscles,
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FIGURE 2 | (a) Trajectories (n = 8) plan relative to the facial nerve. (b) Schematic representation: five measurement points planned relative to the origin of the facial
nerve in the drill axis (OFN) for the lateral trajectories. Five measurement points planned relative to the facial nerve canal (FC) in the frontal trajectories. Lateral distance
(LD) planned between 0.00mm and 0.5mm. Drill trajectory to nerve closest distance defined as CD. (c) Stimulation probe, same diameter as the drill, four different
stimulation configurations, bipolar 1 (red), bipolar 2 (dark blue), bipolar 3 (blue) and monopolar (light blue). The monopolar configuration is measured with needle anode
near the sternum.
orbicularis oculi, and oris; a ground and a stimulation-return
needle were placed central to the nose bridge. To verify correct
placement of the measuring needles, a positive control method
previously describe in Ansó et al. (25) was used. In case one
or both channels would depict no compound muscle action
potential (CMAP) above threshold (100 µV), the corresponding
measuring needle was repositioned in the facial muscle.
Drilling and Nerve Monitoring System
The HEAROTM system (CAScination AG, Switzerland) is a
neurotological surgical robotic system. It integrates a 5DoF
surgical robotic manipulator, an optical tracking camera and
a task-specific facial nerve monitoring system. To assess the
performance of the nerve monitoring system all integrated
safety mechanisms were disabled. The nerve monitoring system
consists of a navigated multipolar stimulating probe, stimulation,
and monitoring hardware and dedicated graphical user interface
functionality to carry out all necessary measurements.
The stimulating probe (Figure 2c) is based on a previously
reported design (24), to enable bipolar (i) and monopolar (ii)
stimulation with a cathode electrode at the tip and four anode
configurations: (i) three concentric anodes rings (configurations
B1,2,3) distally distributed behind the tip of the probe (distances d
= 2, 4, and 7mm); (ii) a needle anode electrode placed in a far-
field location relative to the stimulating tip acts as anode of the
monopolar stimulation. The stimulating probe is navigated via
tracking markers integrated in the housing to ensure its complete
insertion into the drilled tunnel during facial nerve stimulation.
Robotic Guided Nerve Monitoring
Lateral drilling trajectories were randomly selected and loaded
to the system, to ensure the ENT surgeon was blinded. Drilling
commenced with pre-defined drilling parameters (drilling speed:
1,000 RPM, feed forward rate: 0.5 mms−1) and irrigation with
saline solution (NaCl 0.9%, room temperature). Upon reaching
the first measurement point (Figure 2, P1), the drill was removed,
and the drilled tunnel flushed (NaCl 0.9%) for consistency
in electrode-tissue contact properties. The FNM probe was
inserted to the end of the tunnel and an electrical impedance
check of the probe electrodes was done prior to application
of the stimulating protocol. Then a ramp of 11 stimulation
intensities (0.2, 0.25, 0.3, 0.35, 0.4, 0.5, 0.75, 1.0, 1.25, 1.5,
2.0mA) was applied to each of the channels of the probe
with duration of 250 µs (see Supplemental Digital Content 1
(Supplementary Video 1), which shows how the robotic system
drills to the next measurement point, the insertion of the FNM
probe and the stimulation protocol).
Recorded EMG responses were examined in a 50ms search
window after a 3ms rejection period following the stimulation
pulse. The minimum current intensity that produced an CMAP
response above threshold (100 µV) was determined and the
result for each channel presented to the ENT surgeon (Figure 3).
If the stimulation intensity of electrode configuration Bipolar 1
was above 0.35mA, the ENT surgeon continued drilling to the
next measurement point, otherwise the ENT surgeon stopped.
Upon completion of all drillings and FNM measurements,
subjects were euthanized, and the mastoid removed and
preserved in formalin for post-mortem analysis.
Post-mortem Assessment
Drill Trajectory to Facial Nerve Distance Assessment
Mastoids were µCT imaged (isotropic 18µm, Scanco µCT
40, Scanco Medical, Switzerland). Drilled trajectories and the
facial nerve channel were manually segmented (Amira, FEI,
United States). Spatial positions of the measurement points
(Pi) were determined along the segmented trajectory axes and
Frontiers in Surgery | www.frontiersin.org 4 October 2019 | Volume 6 | Article 58
Ansó et al. Nerve Monitoring During Robotic Drilling
FIGURE 3 | Nerve monitoring workflow: using a surgical robot and a stimulation probe, the surgeon follows this workflow to determine if it is safe to continue to drill or
if she should stop. EMG data of only one EMG channel and only for stimulation electrode configuration Bipolar 1 is represented.
the distance between the trajectory and the facial nerve were
measured (Matlab, The Mathworks, 2016a). The minimum
closest distance measured between each drilled tunnel and the
FN was defined as CDmin (Figure 2). The trajectories were
classified in two groups: (i) lateral and (ii) frontal, and lateral
trajectories were subcategorized as facial nerve (CDmin) above
or below 0.1mm. Each trajectory was labeled as X.Y with X
being defined as the subject number (1–3) and Y as the trajectory
number within the subject (0–7) (e.g., trajectory 1.0 stands
for subject1-trajectory0).
Histopathology to Determine Structural Nerve
Damage
Histopathologic inspection was used to study structural nerve
integrity and potential damage in all subjects.Mastoid bones were
first stored in EDTA for initial decalcification, and then, bones
were gently decalcified using a 10% formic acid base (Anapath
GmbH) until they became suitably soft to be sliced. Sections
were taken at an approximate thickness of 4µm, and at steps of
60µm. The resulting sections (50–60 per subject) were stained
by hematoxylin and eosin (H&E), before undergoing histological
evaluation. Pictures were taken by an UC30 camera.
FNM Performance to Determine Critical Nerve
Proximity
For the prospective assessment of FNM (Subjects 2–3), each
measurement point was classified as “outside” or “inside”
the nerve canal based on visual inspection in the histology
slices. Sensitivity and specificity were calculated comparing the
histology assessment with the intraoperative FNM “unsafe” vs.
“safe” assessment. For comparison of these findings with the
previous retrospective pre-clinical study (25, 30), we replaced
not drilled/measured points by a best/worst case scenario.
To calculate confidence intervals, the efficient score method
corrected for continuity was used (31). All measurement points
(S1–S3) were retrospectively classified based on the measured
distance to the facial nerve in the µCT images. Positive and
negative predictive values were determined (PPV and NPV,
respectively) for all stimulation intensities and distances for
which PPV and NPV were above 95%. Youden’s J-test (32) was
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FIGURE 4 | Representative trajectories of the training subject, stimulation thresholds of the FNM (bottom row), with the decision thresholds and the decisive electrode
configuration marked in red, and electrode configurations Monopolar, Bipolar 2 and Bipolar 3 (blue). µCT (middle row), drill outlined in turquoise, measurement points
marked red, facial nerve outlined in yellow. Histology (top row) with H&E staining, facial nerve assessment marked with a star. (a) 1.0: lateral distance > 0.4mm, no
warning from system. (b) 1.1: lateral distance < 0.0mm, stimulus threshold below 0.35mA indicates an emitted system warning at the first FNM point. (c) 1.5: frontal
trajectory with final nerve distance < 0.1mm, the system warned at the deepest FNM point.
used to derive the highest sensitivity and specificity result as a
function of stimulation intensity.
RESULTS
A total of 24 trajectories were drilled in three subjects, each tunnel
consisting of up to five measurement points at varying distances
from the facial nerve canal. During the experiment, breakage
of the bony walls during insertion of the probe (trajectory 3.6)
lead to exclusion of one trajectory. Difficulties to determine
the location of the facial nerve in the post-mortem imagery
lead to exclusion of three more trajectories (exclusion 4/24
trajectories; inclusion 20/24 trajectories). AfterµCT, we classified
the trajectories in three types based on facial nerve distance:
(a) lateral and FN distance > 0.1mm (n = 6), (b) lateral and
FN distance < 0.1mm (n = 6), and (c) frontal (n = 8). In
total, 96 FNM points were assessed, 40 FNM points in subject 1
(training trajectories) and 56 points in subjects 2, 3 (prospective
trajectories). Facial nerve distances ranged from 0.0 to 1.5mm,
with 35 points (prospective, 35/56 = 62.5%) below 0.4mm
(range of interest of this study). An overview of the recorded
CMAP data (from monopolar stimulation) can be found on the
Supplemental Digital Content 2 (Supplementary Data Sheet 1),
which shows the CMAP responses to stimulation for each
measurement point.
Stimulation Thresholds vs. Potential Facial
Nerve Damage
Training Trajectories
All trajectories were drilled to the deepest measurement
point. Figure 4 shows three representative trajectories of the
training subject. Nerve monitoring suggested trajectories 1.0
(Figure 4a) and 1.4 with distances to the facial nerve above
0.1mm (Bipolar 1 > 0.35mA), confirmed in µCT (CDmin
> 0.2mm). In lateral trajectories 1.1 (Figure 4b), 1.2 and
1.3 the FNM system suggested critical FN proximity below
0.1mm and subsequently the system warns the ENT surgeon
(Bipolar 1 ≤ 0.35mA), confirmed in µCT (CDmin < 0.0mm).
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FIGURE 5 | Stimulation Thresholds of the FNM (bottom row), with the decision thresholds and the decisive electrode configuration marked in red, bipolar 2,3 and
monopolar (blue). µCT (middle row), drill (turquois), measurement points marked green/red (go/stop) depending on the FNM assessment, facial nerve (yellow). CD:
closest distance between drill and facial nerve in mm in each measurement point. Histology (top row) with H&E staining, Facial nerve assessment marked with a star.
(a–c) Lateral trajectories with FN distance ≥ 0.2mm; (d–g) Lateral trajectories with FN distance ≤ 0.1mm; (h–l) Frontal trajectories with FN distance ≤ 0.1mm.
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In the frontal trajectories 1.5 (Figure 4c), 1.6, and 1.7,
the FNM determined critical nerve distance at the deepest
measurement point (P5), confirmed in µCT (CDmin > 0.2mm).
Histopathology determined structural damage to the facial nerve
in trajectory 1.1 (Figure 4b).
Prospective Trajectories
In 49/56 points, the system correctly concluded it was uncritical
to continue drilling. From the remaining seven points, four
were correctly identified to be closer to the nerve than 0.1mm
(Figures 5i–l) and in three points the drill contacted the fallopian
canal with no prior warning from the FNM (Figures 5e,g,h).
All point along the three lateral trajectories with distances >
0.1mm (Figures 5a–c) were correctly classified. Of the four
lateral trajectories with distances < 0.1mm to the facial nerve
(Figures 5d–g), the FNM system missed to identify two critical
trajectories (Figures 5e,g). Five trajectories approached the facial
nerve frontally (Figures 5h–l). In three frontal trajectories the
system recommended aborting the drill process before reaching
the last point (Figures 5i–k). In one frontal trajectory the
FNM detected critical nerve distance in the last measurement
point (Figure 5l). In one frontal trajectory FNM suggested FN
proximity < 0.1mm based on B2 (intensity of 0.35mA at P3) but
missed to indicate it based on Bipolar 1.
No Structural Damage to the Facial Nerve
in Prospective Trajectories
In the prospective trajectories, no structural damage to the facial
nerve was observed in any of the histology slices for any of
the drilled trajectories. Trajectories 2.5 and 3.5 (Figures 5h,k)
were identified close to the facial nerve (distance < 0.1mm)
with hemorrhage and tissue debris in the trajectories. Contact
to the epineurium surrounding the facial nerve was determined
in trajectories 2.3, 2.5, 3.4, 3.5 (Figures 5e,g,h,k). No structural
damage was observed to any of the nerve fascicles of the
four lateral trajectories with distances < 0.1mm (Figure 6).
The complete histopathology analysis is in Supplemental Digital
Content 3 (Supplementary Table 1), with each trajectory relative
to the facial nerve and a region of interest in the facial nerve at a
magnified scale.
Stimulation Threshold as Function of
Facial Nerve Distance
The measured distance to the facial nerve in function of the
stimulation intensity (0.2–2mA) showed a wide spread (0–
1.5mm; Figure 7a). In the lower stimulation intensities (0.2–
0.5mA), monopolar, bipolar 3, and bipolar 2 showed a wider
spread of distances (up to 0.9mm) compared to Bipolar 1 (up
to 0.4mm; Figure 7b). From the measurement points at facial
FIGURE 6 | Histopathology of lateral trajectories at critically low distance to the fallopian channel (facial nerve canal). Decalcified mastoid bone slices with hematoxylin
and eosin staining. (a) Trajectory 2.3–Facial nerve in close proximity to the drilled hole but without visible destruction of the nerve fascicles. (b) Trajectory 2.4 with 6µm
distance (measured in µCT) between drill and fallopian canal, the black arrow indicating intact facial nerve fascicles. (c) Trajectory 3.0 with 10µm distance between
drill and fallopian channel and with intact facial nerve fascicles. (d) Trajectory 3.4 with facial nerve not visible (due to a technical artefact) and an intact epineurium.
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FIGURE 7 | (a) Scatter plot of the stimulation thresholds and the corresponding measured distances to the facial nerve, for subjects 1,2, and 3. (b) Zoom into the
lower stimulation thresholds, (c) number of points closer to the facial nerve than 0.1mm which generate a CMAP at a given stimulus threshold, percentage only
shown for Bipolar 1 (d) Cumulative percentage—percentage of points closer to the facial nerve than 0.1mm recognized by a given stimulus threshold.
nerve distances below 0.1mm (37 points in all three subjects),
75% of the times the stimulus threshold was below 0.5mA
(configuration B1, Figure 7c). For the pre-defined threshold of
0.35mA, 63% of the points were recognized by the system as
distances below 0.1mm. To reach 95% true positive detections
at facial nerve distance < 0.1mm, a stimulation intensity of
1.5mA was needed (Figure 7d), but this would have resulted
in a large amount of false positive detections (0.1mm < FN
distance < 1.5mm, Figure 7a).
FNM Performance to Determine Critical FN
Proximity
Evaluation of the prospective use of the FNM system based
on the histopathology resulted in a sensitivity of 0.57 (95%
confidence interval (CI), [0.2, 0.88]) and a specificity of 1 (95%
CI, [0.91, 1]). Providing the four measurement points which
were not drilled (Figures 5i–k) would have been classified as
critical distance (expected scenario), the sensitivity was 0.73 (95%
CI, [0.39, 0.93]) and specificity 1 (95% CI, [0.91, 1]). From the
retrospective assessment (Subject 1, 2, and 3), the sensitivity
resulted in 0.68 (95% CI, [0.49, 0.84]) and specificity 0.97 (95%
CI, [0.89, 0.99]) (J = 0.65). The positive predictive value was 0.91
reached at distances < 0.08mm (95% CI, [0.69, 0.98]); and the
negative predicted value was 0.88 at distances> 0.0mm (95% CI,
[0.78, 0.94]).
Depending on the stimulation threshold, the system is able to
discriminate different distance ranges to the facial nerve with a
positive predictive value > 95% (Figure 8). Lower stimulation
intensities resulted in narrow distance ranges, for example,
in B1 configuration at 0.35mA the drilled trajectories were
within 0.03mm from the facial nerve. Increasing stimulation
intensities widened the distance ranges, for example at 0.5mA
(B1) the trajectories were within 0.3mm from the facial nerve.
Stimulation amplitude increased with distance for Bipolar
configuration B1, whereas with bipolar B3 andmonopolar almost
no differences were found in the distance range < 0.6 mm.
DISCUSSION
In this study, we present a prospective validation of a previously
proposed nerve monitoring approach to detect facial nerve
proximity during robotic cochlear implantation procedure.
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FIGURE 8 | For different stimulation threshold levels, given a CMAP response
>100 µV with a positive predictive value PPV > 95%, the trajectory will be
found in the distance range depicted in colors. For example, with a positive
response measured in B1 at 0.5mA, the distance between the trajectory and
the facial nerve is <0.3mm.
Experimental results demonstrated that facial nerve monitoring
can correctly warn the surgeon to stop robotic operation when
the drill trajectory contacts the fallopian canal (facial nerve
channel). Although the drill trajectory may have contacted the
channel before the system has warned, structural preservation
of the facial nerve is still guaranteed with the proposed nerve
monitoring settings. Functional preservation of the facial nerve
at the critical distance range <0.1mm could not be assessed and
remains unknown.
Histological assessment showed that in all prospective
trajectories the system warned and stopped before the facial
nerve was damaged. All measurement points which were outside
the fallopian canal were correctly identified. In subject 1
(training trajectories), the nerve monitoring assessment correctly
identified lateral trajectories that intersected and damaged
the facial nerve (Figure 4b). In the prospective trajectories,
in three measurement points the drill trajectory terminated
inside the fallopian canal without previous warning of the
FNM system (false negatives). While the system works well in
most trajectories, there are borderline trajectories with distance
below 0.1mm when the drill approaches laterally the facial
nerve channel which the system cannot yet correctly identify
(Figure 6). Due to the prospective study set-up there was a
limited number of measurement points classified as inside the
nerve, which biases (underestimates) the sensitivity of the system
compared to specificity (sensitivity 0.73, specificity 1).
The system had previously been used in a clinical trial (25) to
prevent mechanical destruction of the facial nerve. In patients,
a safety margin > 0.4mm had been implemented (13, 25).
Here distances between 0 and 0.4mm were further studied to
potentially decrease the safety margin defined in future clinical
studies. In a previous pre-clinical in vivo study (24), we tested
an initial version of the system and explored stimulation settings
(intensities) and probe configurations (bipolar and monopolar).
We found that 0.3mA and bipolar stimulation (B1) could
detect a transition into the nerve channel. Now, with a newly
manufactured stimulation probe system, we found that below
0.35mA (configuration B1) avoided structural damage of the
facial nerve, but an intensity of 0.4mAwould potentially increase
the sensitivity to detect critical proximity below 0.1mm and is
suggested for future studies (Figure 8).
The previous clinical study (25) suggested that the nerve
monitoring information from configurations B2 and B3 may be
redundant at distances > 0.4mm. Here, we further suggest that
even at the distance range < 0.4mm, the configurations B2,
B3, and monopolar suggest similar correlates of nerve distance
for stimulation intensities below 0.5mA (Figure 8). A probe-
based measuring system allows to implement a large amount of
stimulation settings, however only a limited number of points
can be measured (due to time restrictions). Therefor we argue
in the future the number of electrode configurations could be
reduced from four to two, e.g., B1 and B2 or B1 and monopolar.
Additionally, integrating the electrodes in the surgical drill
bit will increase spatial resolution, save time and reduce the
complexity for the surgeon.
Although the approach was able to ensure structural
(anatomical) preservation of the facial nerve, here we did not
evaluate a correlation between structural damage and functional
damage. Thus, one practical limitation of our study is that
only structural damage could be assessed with microcomputed
tomography or histopathology. Standard assessment of facial
nerve function in an animal model may result cumbersome
and ethically inappropriate. We have applied functional testing
during our first clinical study in patients and it requires awake
state and collaboration of the patients before and after the
operation (30).
An alternative to assess functional nerve damage in an
animal model is recording a positive control stimulation
channel at the brainstem level before the facial nerve mastoid
region. Changes in amplitude of the evoked muscle action
potentials at supramaximal stimulation intensity is correlated
to intraoperative iatrogenic nerve damage (e.g., <50%) (33).
The viability of this method to test nerve integrity in the
mastoid region has not yet been studied, and its efficacy in our
animal model set-up is still unknown. Due to the “somatotopic”
distribution of the facial nerve fibers (34), in future studies we
suggest using a larger number of EMG needles to be able to
precisely assess minimal changes in integrity of the nerve.
The criteria for stopping the robotic drilling is based on a pre-
defined stimulation intensity and EMG-triggered response, but
the surgeon still needs to decide. This is especially relevant in
border-line cases, e.g., when the EMG signal is contaminated with
ambient noise or interference, or when the peak EMG value is
close but not yet above threshold level. In the operating room, the
final decision of the surgeon is based on a combination of nerve
monitoring with the primary layers of safety i.e., accuracy of the
registration process and direction of drilling error relative to the
plan based on intraoperative imaging before the facial nerve (12).
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The nerve monitoring measuring set-up uses a simplified
model with two variables (stimulation intensity and muscle
evoke potentials amplitude) to derive facial nerve distance. This
simplified model ignores anatomical and bone quality properties
which do influence the physical path of the electrical current
(volume conductor).We assume the unexpected high stimulation
intensities in some of the measured points (e.g., Figures 5f,g)
are due to such anatomical and structural differences. In the
future, tissue impedance and computational modeling from
pre-operative computed tomography images (30, 35) could be
investigated to calibrate intensity thresholds at the facial nerve
canal, specific to each patient.
To conclude, facial nerve monitoring integrated in a
surgical robotic system supported the surgeon to enable
facial nerve structural preservation prospectively. Although
structural preservation is a primary requirement during robotic
drilling in the mastoid, it remains unknown if functional
nerve integrity is ensured within distances of 0.1mm or
below. The system and approach are specific to not give
false alarms in case of trajectories being drilled within the
planned safety distance margin (>0.4mm); and the system
proved to correctly warn before the drill could structurally
damage the facial nerve in frontal trajectories. Lateral distances
below 0.1mm cannot always be discriminated and should
be avoided.
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